Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:AVAI)

0.4600 -0.0195 (-4.07%)
Streaming Delayed Price Updated: 1:43 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 59,091
Open 0.4564
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.4795
Today's Range 0.4200 - 0.4800
52wk Range 0.2191 - 0.8700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:RLYB),(NASDAQ:BTAI),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies’ Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
Las Vegas, NV – July 22, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions using both artificial intelligence (AI)... 
Via FinancialNewsMedia
Topics Artificial Intelligence

Performance

YTD
-5.2%
-5.2%
1 Month
-24.5%
-24.5%
3 Month
-40.3%
-40.3%
6 Month
-28.1%
-28.1%
1 Year
-37.8%
-37.8%

More News

Read More
Ainnova Tech Reaches Major FDA Milestone in AI-Powered Diabetic Retinopathy Detection
Via AB Newswire
Topics Artificial Intelligence
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
Via FinancialNewsMedia
Topics Artificial Intelligence
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
Via FinancialNewsMedia
Topics Artificial Intelligence
Healthcare’s $110B AI Surge Is Picking Up Speed—and It’s Just the Beginning
Via FinancialNewsMedia
Topics Artificial Intelligence
Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
New AI Rollouts Signal Shift From Hype to Healthcare Reality
Via FinancialNewsMedia
Topics Artificial Intelligence
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies’ JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies
Via FinancialNewsMedia
Topics Artificial Intelligence
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
Via FinancialNewsMedia
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
Via FinancialNewsMedia
Topics Artificial Intelligence
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
Real-World Deployments Signal AI Healthcare Is Ready for Scale
Via FinancialNewsMedia
Topics Artificial Intelligence
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform
Via ACCESS Newswire
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
Via ACCESS Newswire
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
Via FinancialNewsMedia
Topics Artificial Intelligence
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
Via FinancialNewsMedia
Topics Artificial Intelligence
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
Via ACCESS Newswire
Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company’s Vision AI Platform Technology
Via ACCESS Newswire
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
From FN Media Group LLC
Via GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
Via FinancialNewsMedia
Topics Artificial Intelligence

Frequently Asked Questions

Is AVAI publicly traded?
Yes, AVAI is publicly traded.
What exchange does AVAI trade on?
AVAI trades on the OTC Traded
What is the ticker symbol for AVAI?
The ticker symbol for AVAI is AVAI on the OTC Traded
What is the current price of AVAI?
The current price of AVAI is 0.4600
When was AVAI last traded?
The last trade of AVAI was at 08/19/25 01:43 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS